Company news

Praxis Precision Medicines, Inc. news in 2022

Praxis Precision Medicines, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

December 12, 2022

Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting

November 27, 2022

Praxis Precision Medicines to Advance PRAX-562 Phase 2 Study in Pediatric Patients with Developmental and Epileptic Encephalopathies

November 27, 2022

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results

November 8, 2022

Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference

September 20, 2022

Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing

September 19, 2022

Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision Medicines’ PRAX-222 IND Filing

September 19, 2022

Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference

September 6, 2022

Praxis Precision Medicines Provides Updates on Clinical Stage Pediatric Epilepsy Programs

September 6, 2022

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results

August 7, 2022

Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference

August 2, 2022

Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder

June 5, 2022

Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone

May 22, 2022

Praxis Precision Medicines Reports Positive Topline Results from PRAX-944 Phase 2a Study in Essential Tremor Patients

May 8, 2022

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results

May 8, 2022

Praxis Precision Medicines to Present at BofA Securities 2022 Healthcare Conference

May 3, 2022

Praxis Precision Medicines to Provide Corporate Update and Report First Quarter 2022 Financial Results on Monday, May 9, 2022

May 1, 2022

Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy Day

April 26, 2022

Praxis Precision Medicines to Host Epilepsy Day on April 27, 2022

April 12, 2022

Praxis Precision Medicines to Present Data from PRAX-944 for Essential Tremor at 2022 American Academy of Neurology Annual Meeting

March 31, 2022

Praxis Precision Medicines to Present at Stifel’s 4th Annual CNS Day

March 20, 2022

Praxis Precision Medicines to Present at Cowen’s 42nd Annual Healthcare Conference

February 28, 2022

Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

February 27, 2022

Praxis Precision Medicines to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022

February 21, 2022

Praxis Precision Medicines Announces Publication of Preclinical Data Highlighting Differentiated and Potent Antiepileptic Activity of PRAX-562

January 17, 2022

Calls in 2022

Decks in 2022